Structures by: Siddegowda M. S.
Total: 28
5-{5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-pyridyl}-2-methylpyridinium 2,4,6-trinitrophenolate
C18H16ClN2O2S,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o107-o108
a=9.02500(10)Å b=12.74960(10)Å c=21.8011(3)Å
α=90.00° β=98.1140(10)° γ=90.00°
Enrofloxacinium picrate
C19H23FN3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o432-o433
a=7.2111(7)Å b=12.5766(7)Å c=16.2362(4)Å
α=105.556(2)° β=96.367(6)° γ=96.223(7)°
4-(4-Chlorophenyl)piperidin-4-ol
C11H14ClNO
Acta Crystallographica Section E (2010) 66, 3 o562
a=11.3706(10)Å b=9.5204(8)Å c=10.6164(9)Å
α=90.00° β=108.458(8)° γ=90.00°
4,6-Dichloro-5-methoxypyrimidine
C5H4Cl2N2O
Acta Crystallographica Section E (2010) 66, 2 o408
a=13.6545(19)Å b=3.9290(6)Å c=13.0275(18)Å
α=90.00° β=90.00° γ=90.00°
Cinnarizinium dipicrate
C26H30N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o500-o501
a=15.1987(2)Å b=10.09130(17)Å c=25.0724(3)Å
α=90.00° β=95.9170(14)° γ=90.00°
(<i>RS</i>)-4-(3-carboxy-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinolin-7-yl)- 2-methylpiperazin-1-ium 2,4,6-trinitrophenolate
C17H20F2N3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o483-o484
a=10.9314(4)Å b=11.6748(4)Å c=12.0530(4)Å
α=92.969(3)° β=115.555(3)° γ=109.852(3)°
10,10-Dimethylanthrone
C16H14O
Acta Crystallographica Section E (2010) 66, 4 o808-o809
a=11.2438(6)Å b=12.1105(6)Å c=15.1025(8)Å
α=107.9550(10)° β=98.7340(10)° γ=111.7640(10)°
1-[2-(2-Bromophenyl)ethyl]-4-chloro-2-nitrobenzene
C14H11BrClNO2
Acta Crystallographica Section E (2010) 66, 12 o3358
a=15.7756(4)Å b=7.3795(2)Å c=11.5236(3)Å
α=90.00° β=90.00° γ=90.00°
Levocetirizinium dipicrate
C21H27ClN2O32,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 12 o3167
a=11.24440(10)Å b=15.7720(2)Å c=20.6204(2)Å
α=90.00° β=95.9980(10)° γ=90.00°
1-(2-Hydroxyethyl)-4-[3-(2-trifluoromethyl-9<i>H</i>-thioxanthen-9- ylidene)propyl]piperazine-1,4-diium dichloride
C23H27F3N2OS2,2(Cl)
Acta Crystallographica Section E (2011) 67, 8 o2079-o2080
a=34.1750(17)Å b=7.1613(3)Å c=22.6351(11)Å
α=90° β=115.307(6)° γ=90°
9-[3-(Dimethylamino)propyl]-2-trifluoromethyl-9<i>H</i>-thioxanthen-9-ol
C19H20F3NOS
Acta Crystallographica Section E (2011) 67, 8 o1883
a=7.6183(3)Å b=13.9605(4)Å c=17.4172(7)Å
α=90.00° β=101.053(4)° γ=90.00°
1-(2-Hydroxyethyl)-4-{3-[(<i>E</i>)-2-(trifluoromethyl)-9<i>H</i>-thioxanthen- 9-ylidene]propyl}piperazine-1,4-diium bis(3-carboxyprop-2-enoate)
C23H27F3N2OS2,2(C4H3O4)
Acta Crystallographica Section E (2011) 67, 8 o2017-o2018
a=6.4175(2)Å b=9.6185(4)Å c=25.5771(10)Å
α=96.377(4)° β=96.295(3)° γ=92.774(3)°
Cyclobenzaprinium salicylate
C20H22N,C7H5O3
Acta Crystallographica Section E (2011) 67, 7 o1584
a=7.4700(8)Å b=10.8408(12)Å c=14.9724(16)Å
α=76.073(2)° β=77.3570(10)° γ=72.574(2)°
Melitraceninium chloride
C21H26N,Cl
Acta Crystallographica Section E (2011) 67, 7 o1725
a=15.0129(18)Å b=8.8092(11)Å c=14.0135(17)Å
α=90.00° β=91.506(2)° γ=90.00°
2,2-Diphenyl-4-(piperidin-1-yl)butanamide
C21H26N2O
Acta Crystallographica Section E (2011) 67, 7 o1827
a=18.1070(12)Å b=10.3025(9)Å c=9.6150(6)Å
α=90.00° β=90.00° γ=90.00°
3-Chloro-<i>N</i>-(4-methoxyphenyl)propanamide
C10H12ClNO2
Acta Crystallographica Section E (2011) 67, 11 o2868
a=9.6326(3)Å b=8.6650(2)Å c=25.7944(8)Å
α=90.00° β=90.00° γ=90.00°
Opipramolium fumarate
C23H30N3O,C4H3O4
Acta Crystallographica Section E (2011) 67, 9 o2296
a=8.9116(3)Å b=6.7167(3)Å c=20.6377(8)Å
α=90.00° β=98.685(3)° γ=90.00°
Diphenylmethyl benzoate
C20H16O2
Acta Crystallographica Section E (2013) 69, 1 o81
a=5.75357(19)Å b=16.0368(5)Å c=8.3114(3)Å
α=90.0° β=95.340(3)° γ=90.0°
Opipramol
C23H29N3O
Acta Crystallographica Section E (2011) 67, 7 o1598
a=12.6215(2)Å b=10.5929(2)Å c=14.3629(2)Å
α=90.00° β=90.9660(10)° γ=90.00°
3-(5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5-ylidene)- <i>N</i>,<i>N</i>-dimethylpropanaminium chloride
C20H22N,Cl
Acta Crystallographica Section E (2011) 67, 7 o1846
a=32.0959(7)Å b=32.0959(7)Å c=13.7578(5)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Methylphenyl)benzonitrile
C14H11N
Acta Crystallographica Section E (2011) 67, 7 o1647
a=7.6726(4)Å b=11.4037(5)Å c=12.2426(5)Å
α=90.00° β=90.00° γ=90.00°
1-(5,5-Dioxido-10<i>H</i>-phenothiazin-10-yl)ethanone
C14H11NO3S
Acta Crystallographica Section E (2011) 67, 7 o1702
a=12.5715(6)Å b=8.7648(4)Å c=11.5828(5)Å
α=90.00° β=92.142(4)° γ=90.00°
3-(5,5-dioxophenothiazin-10-yl)-<i>N</i>,<i>N</i>,2-trimethylpropanaminium chloride
C18H23N2O2S,Cl
Acta Crystallographica Section E (2011) 67, 8 o1875
a=7.6364(7)Å b=10.4177(9)Å c=12.4732(10)Å
α=103.478(7)° β=90.624(7)° γ=109.852(8)°
Methyl 2-(4-hydroxybenzoyl)benzoate
C15H12O4
Acta Crystallographica Section E (2011) 67, 8 o1994
a=8.9017(12)Å b=13.9940(17)Å c=10.0473(12)Å
α=90.00° β=94.687(12)° γ=90.00°
2,2-Diphenylacetamide
C14H13NO
Acta Crystallographica Section E (2011) 67, 8 o1992-o1993
a=5.1687(3)Å b=28.5511(13)Å c=7.8006(4)Å
α=90.00° β=98.152(5)° γ=90.00°
[3-(5-Hydroxy-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5- yl)propyl]dimethylammonium 3-carboxyprop-2-enoate
C20H24NO,C4H3O4
Acta Crystallographica Section E (2011) 67, 10 o2600-o2601
a=9.2115(2)Å b=11.5840(2)Å c=10.4640(2)Å
α=90.00° β=101.591(2)° γ=90.00°
3,3-Dimethyl-2-benzofuran-1(3<i>H</i>)-one
C10H10O2
Acta Crystallographica Section E (2012) 68, 1 o113
a=14.3537(9)Å b=7.0069(5)Å c=8.2605(5)Å
α=90° β=90° γ=90°
6-Chloro-2-chloromethyl-4-phenylquinazoline 3-oxide
C15H10Cl2N2O
Acta Crystallographica Section E (2014) 70, 4 o440-o441
a=8.2030(3)Å b=14.3203(5)Å c=11.8477(4)Å
α=90° β=105.016(4)° γ=90°